The conservative view: is it necessary to implant a stent into the dopamine transporter?
- PMID: 24824446
- PMCID: PMC4561504
- DOI: 10.1111/bph.12766
The conservative view: is it necessary to implant a stent into the dopamine transporter?
Abstract
This article is a reply to De Felice LJ and Cameron KN (2015). Comments on ‘A quantitative model of amphetamine action on the serotonin transporter’, by Sandtner et al., Br J Pharmacol 171: 1007–1018. Br J Pharmacol 172: this issue, doi:
Figures
Comment on
-
A quantitative model of amphetamine action on the 5-HT transporter.Br J Pharmacol. 2014 Feb;171(4):1007-18. doi: 10.1111/bph.12520. Br J Pharmacol. 2014. PMID: 24251585 Free PMC article.
-
Comments on 'A quantitative model of amphetamine action on the serotonin transporter', by Sandtner et al., Br J Pharmacol 171: 1007-1018.Br J Pharmacol. 2015 Oct;172(19):4772-4. doi: 10.1111/bph.12767. Br J Pharmacol. 2015. PMID: 24824549 Free PMC article.
References
-
- Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. CGTP Collaborators. The Concise Guide to Pharmacology 2013/14: Transporters. Br J Pharmacol. 2013;170:1706–1796. doi: 10.1111/bph.12450. - DOI - PMC - PubMed
-
- DeFelice LJ, Cameron Sandtner, et al., editors. Comments on ‘A quantitative model of amphetamine action on the serotonin transporter’. Br J Pharmacol. 2014 (2014). doi: 10.1111/bph.12767. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
